- Home
- BCAB vs GENK Comparison
BCAB vs GENK Comparison
Compare BCAB & GENK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCAB
- GENK
- Stock Information
- Founded
- BCAB 2007
- GENK 2011
- Country
- BCAB United States
- GENK United States
- Employees
- BCAB N/A
- GENK N/A
- Industry
- BCAB Medicinal Chemicals and Botanical Products
- GENK Restaurants
- Sector
- BCAB Health Care
- GENK Consumer Discretionary
- Exchange
- BCAB Nasdaq
- GENK Nasdaq
- Market Cap
- BCAB 27.0M
- GENK 23.6M
- IPO Year
- BCAB 2020
- GENK 2023
- Fundamental
- Price
- BCAB $0.45
- GENK $4.56
- Analyst Decision
- BCAB Buy
- GENK Strong Buy
- Analyst Count
- BCAB 2
- GENK 3
- Target Price
- BCAB $1.00
- GENK $12.17
- AVG Volume (30 Days)
- BCAB 538.8K
- GENK 38.0K
- Earning Date
- BCAB 05-06-2025
- GENK 05-13-2025
- Dividend Yield
- BCAB N/A
- GENK N/A
- EPS Growth
- BCAB N/A
- GENK 62.05
- EPS
- BCAB N/A
- GENK 0.13
- Revenue
- BCAB $11,000,000.00
- GENK $208,380,000.00
- Revenue This Year
- BCAB N/A
- GENK $20.48
- Revenue Next Year
- BCAB N/A
- GENK $21.64
- P/E Ratio
- BCAB N/A
- GENK $35.56
- Revenue Growth
- BCAB N/A
- GENK 15.12
- 52 Week Low
- BCAB $0.24
- GENK $3.99
- 52 Week High
- BCAB $3.53
- GENK $13.12
- Technical
- Relative Strength Index (RSI)
- BCAB 59.13
- GENK 51.60
- Support Level
- BCAB $0.44
- GENK $4.30
- Resistance Level
- BCAB $0.58
- GENK $4.63
- Average True Range (ATR)
- BCAB 0.06
- GENK 0.23
- MACD
- BCAB 0.00
- GENK 0.08
- Stochastic Oscillator
- BCAB 64.11
- GENK 100.00
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.
About GENK GEN Restaurant Group Inc.
GEN Restaurant Group Inc operates an Asian casual dining restaurant chain, offering an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables. It operates 43 Gen Korean BBQ restaurants in the United States.